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Abstract
A new phenotypic test, called the Carbapenem Inactivation Method (CIM), was developed
to detect carbapenemase activity in Gram-negative rods within eight hours. This method
showed high concordance with results obtained by PCR to detect genes coding for the car-
bapenemases KPC, NDM, OXA-48, VIM, IMP and OXA-23. It allows reliable detection of
carbapenemase activity encoded by various genes in species of Enterobacteriaceae (e.g.,
Klebsiella pneumoniae, Escherichia coli and Enterobacter cloacae), but also in non-fermen-
ters Pseudomonas aeruginosa and Acinetobacter baumannii. The CIM was shown to be a
cost-effective and highly robust phenotypic screening method that can reliably detect
carbapenemase activity.
Introduction
The emergence and spread of carbapenemase-producing Gram-negative rods is a worldwide
emerging public health threat [1–3]. Particularly in health care centers, this may pose a major
problem as carbapenems are becoming more frequently needed to treat infections caused by
Gram-negative bacteria that produce extended spectrum beta-lactamases (ESBL) [4,5]. To pre-
vent spread of carbapenemase producers, rapid detection of these bacteria has become impera-
tive [6]. Resistance to carbapenems is assessed in phenotypic susceptibility assays either on
agar plates or in automated microbiology systems. However, high or low minimal inhibitory
concentrations (MICs) do not necessarily reflect the production of carbapenemases, as other
mechanisms such as porin loss or increased efflux pump activity, due to alterations in chro-
mosomally located genes, can also cause resistance [7,8]. Since carbapenemase-encoding genes
are often located on plasmids, this type of resistance is much more likely to spread [9].
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Therefore, distinction between carbapenem-resistance mediated by carbapenemases and resis-
tance mediated by other mechanisms is important for infection control. To identify possible
carbapenemase involvement, PCRs targeting the genes encoding carbapenemases are often em-
ployed [10–12]. These methods can only detect known carbapenemase encoding genes and the
number of carbapenemase encoding genes and allelic variants thereof is expanding rapidly. In
contrast, a phenotypic assay may detect carbapenemase activity irrespective of the carbapene-
mase encoding gene sequence. In 2012, Nordmann et al. reported a new phenotypic test to de-
tect the capability of an isolate to hydrolyse imipenem, the Carba NP test [13,14]. Even though
this method is a huge improvement over methods such as the Modified Hodge Test, the costs
are relatively high and some groups have reported difficulties with the Carba NP test, especially
with mucoid isolates or isolates with weak carbapenemases such as OXA-48 [15]. In these
cases only a subtle color change is observed which can easily be missed. This triggered us to de-
velop an alternative bioassay designated as the Carbapenem Inactivation Method (CIM).
Materials and Methods
Strains and culture media
For validation of the CIM, a selection of 30 Gram-negative isolates was used. This selection in-
cluded isolates obtained from different institutes across the world carrying known carbapene-
mase encoding genes and carbapenem susceptible isolates, according to the submitter
(Table 1). In addition, 694 isolates submitted to the National Institute for Public Health and
the Environment for the national surveillance of carbapenemase-producing Enterobacteriaceae
(CPE) by Dutch medical microbiology laboratories (MMLs) during the first six months of
2012 and the first six months of 2013 were used. For the national surveillance of CPE in the
Netherlands, Dutch MMLs are requested to submit Enterobacteriaceae isolates with an MIC
for meropenem> 0.25 μg/ml. However, more than half of the isolates (411/694, 59%) sent in
for CPE surveillance were non-fermenting Gram-negatives belonging to the genera Pseudomo-
nas and Acinetobacter. Furthermore, 35% of the isolates had MICs below 0.25 μg/ml. Neverthe-
less, all isolates were included in this study.
The species identification, as performed by the MMLs, was confirmed using MALDI-TOF
(Bruker Daltonics GmbH, Bremen, Germany) and the MIC for all isolates was confirmed by E-
test (BioMerieux Inc., Marcy L’Etoile, France). Culturing of isolates was done on Columbia
Sheep Blood (bioTRADING Benelux BV, Mijdrecht, The Netherlands) and Mueller-Hinton
agarplates (Oxoid Ltd, Hampshire, United Kingdom). An overview of all CPE surveillance iso-
lates and their characteristics is displayed in Tables 2 and 3.
The Carbapenem Inactivation Method
To perform the CIM, a suspension was made by suspending a full 10 μl inoculation loop of cul-
ture, taken from aMueller-Hinton or blood agar plate in 400 μl water. Subsequently, a suscepti-
bility-testing disk containing 10 μg meropenem (Oxoid Ltd, Hampshire, United Kingdom) was
immersed in the suspension and incubated for a minimum of two hours at 35°C. After incuba-
tion, the disk was removed from the suspension using an inoculation loop, placed on a Muel-
ler-Hinton agar plate inoculated with a susceptible E. coli indicator strain (ATCC 29522) and
subsequently incubated at 35°C. Inoculation of the Mueller-Hinton agar plate with the indica-
tor strain was done with a suspension of OD595 1.25 (correlates with a McFarland value of 0.5)
streaked in three directions using a sterile cotton swab. If the bacterial isolate produced carba-
penemase, the meropenem in the susceptibility disk was inactivated allowing uninhibited
growth of the susceptible indicator strain. Disks incubated in suspensions that do not contain
carbapenemases yielded a clear inhibition zone. If results are required within the same day,
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they can be read after six hours, but within the setting of our laboratory, we prefer reading re-
sults after overnight incubation (Fig. 1).
PCR to detect the presence of carbapenemase encoding genes
Amultiplex PCR that detects the genes encoding the predominant carbapenemases KPC,
NDM, OXA-48like, VIM and IMP was used. To serve as an internal positive control, primers
detecting the bacterial 23S rRNA gene were incorporated. This multiplex PCR was developed
in-house and combines previously published (OXA-48L [10], IMP [11] and 23S [16]) and
newly designed primers (KPC, NDM and VIM). For PCR, 12.5 μl of QiaGen Multiplex mix
(QiaGen GmbH, Hilden, Germany) was mixed with 2 pmol of forward and reverse primers for
KPC, OXA-48, VIM and 23S and with 6 pmol of the forward and reverse primers for NDM
and IMP and supplemented with water to reach a final volume of 23 μl. Two μl of boilate from
an isolate was added to the mix and 25 PCR cycles of 60 sec denaturation at 95°C, 60 sec
Table 1. Isolates used for validation of the CIM.
Species carbapenemase gene CIM CarbaNP
Klebsiella pneumoniae1 KPC-2 + +
Klebsiella pneumoniae1 NDM-1 + +
Klebsiella pneumoniae1 OXA-48 + +
Klebsiella pneumonia OXA-48 + +
Klebsiella pneumonia - -
Klebsiella pneumonia - -
Klebsiella pneumonia - -
Escherichia coli - -
Escherichia coli - -
Escherichia coli - -
Escherichia coli - -
Escherichia coli - -
Escherichia coli ATCC259221 - -
Enterobacter cloacae - -
Enterobacter cloacae - -
Salmonella Bareilly - -
Salmonella Heidelberg - -
Pseudomonas aeruginosa1 VIM-2 + +
Pseudomonas aeruginosa VIM-2 + +
Pseudomonas aeruginosa1 IMP-1 + +
Pseudomonas aeruginosa1 GIM-1 + +
Pseudomonas aeruginosa1 SPM-1 + +
Pseudomonas aeruginosa AIM-1 + +
Pseudomonas ﬂuorescens BIC-1 + -
Pseudomonas stutzeri1 DIM-1 + +
Acinetobacter baumannii OXA-23 + +
Acinetobacter baumannii OXA-40 + +
Acinetobacter baumannii OXA-58 + +
Acinetobacter baumannii OXA-143 + +
Acinetobacter baumannii1 SIM-1 + +
1subset used for testing robustness
doi:10.1371/journal.pone.0123690.t001
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annealing at 57.5°C and 60 sec elongation at 72°C were run. In addition, Acinetobacter isolates
were tested for the presence of the gene encoding for OXA-23 in a separate PCR [12]. Finally,
for isolates that demonstrated carbapenemase activity using the CIM, but did not yield a PCR
product using the multiplex PCR described above, three additional PCRs were performed.
These separate PCRs, targeting BIC [11] and additional variants of OXA-48L and IMP [17],
were performed using 10 pmol of each primer and the same PCR conditions as the multiplex
PCR.
Table 2. Characteristics of Enterobacteriaceae isolates submitted for CPE surveillance during the first halves of 2012 and 2013.
MIC >0.25 μg/ml MIC 0.25 μg/ml
Enterobacteriaceae species (n) PCR N % n CIM+ n CIM+
Klebsiella pneumoniae (88) IMP 2 2.3 2 2
KPC 5 5.7 5 5
NDM 8 9.1 8 8
OXA-48 26 29.5 25 25 1 1
VIM 1 1.1 1 1
pos. 42 47.7 41 41 1 1
neg. 46 52.3 24 2 22 0
Escherichia coli (43) IMP
KPC
NDM 7 16.3 7 7
OXA-48 13 30.2 12 12 1 1
VIM 1 2.3 1 1
pos. 21 48.8 20 20 1 1




OXA-48 3 4.2 3 3
VIM 1 1.4 1 1
pos. 4 5.6 4 4
neg. 68 94.4 48 0 20 0
Other Enterobacteriaceae(80) IMP
KPC
NDM 1 1.3 1 1
OXA-48
VIM 2 2.5 1 1 1 1
pos. 3 3.8 2 2 1 1
neg. 77 96.3 17 0 60 0
All Enterobacteriaceae (283) IMP 2 0.7 2 2
KPC 5 1.8 5 5
NDM 16 5.7 16 16
OXA-48 42 14.8 40 40 2 2
VIM 5 1.8 4 4 1 1
pos. 70 24.7 67 67 3 3
neg. 213 75.3 101 3 112 0
N, total number of isolates
n, number of isolates within the MIC-category
doi:10.1371/journal.pone.0123690.t002
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Table 3. Characteristics of non-fermenter isolates submitted for CPE during the first halves of 2012 and 2013.
MIC >0.25 μg/ml MIC 0.25 μg/ml
Non-fermenter species (n) PCR N % n CIM+ n CIM+




VIM 43 13.4 43 43
pos. 47 14.7 47 47
neg. 273 85.3 268 1 5 0




VIM 6 9.0 6 6
pos. 8 11.9 8 8
neg. 59 88.1 58 5 1 0
Acinetobacter baumannii (18) IMP
KPC
NDM 1 5.6 1 1
OXA-23* 12 66.7 12 10
OXA-48
VIM
pos. 12 66.7 12 10**
neg. 6 33.3 6 1







neg. 6 100.0 6 0
All non-fermenters (411) IMP 6 1.5 6 6
KPC
NDM 1 0.2 1 1
OXA-23* 12 2.4 12 10
OXA-48
VIM 49 11.9 49 49
pos. 67 16.3 67 65
neg. 344 83.7 338 7 6 0
N, total number of isolates
n, number of isolates within the MIC-category
* OXA-23 PCR was performed on Acinetobacter isolates only
** One Acinetobacter baumannii isolate was found positive for both NDM and OXA-23
doi:10.1371/journal.pone.0123690.t003
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The primer sequences and the expected PCR product sizes are listed in Table 4.
Next-generation sequencing
Four isolates with discrepant results for CIM in comparison to PCR, an E. coli, K. pneumoniae,
A. baumannii and a Proteus mirabilis isolate, have been analyzed using next-
generation sequencing.
DNA was extracted using the QuickExtract Bacterial DNA Extraction Kit (Epicentre,
Madison, USA) according to the manufacturer’s instructions, followed by proteinase K (Qia-
Gen GmbH, Hilden, Germany) digestion and precipitation. Library preparation and sequenc-
ing of bacterial genomes was performed by BaseClear (Leiden, the Netherlands) using the
Illumina Nextera XT kit and the HiSeq 2500 with a paired-end 100 cycles protocol. For detec-
tion of beta-lactamase genes, a reference list of relevant genes was composed based on those
listed on the Lahey Clinic website (http://www.lahey.org/Studies/). Trimmed sequence reads
were mapped to this reference list, after which mapped reads were extracted, assembled into
contigs and antibiotic resistance determinants were identified by BLAST analysis of the result-
ing contigs against the same reference list. Sequence reads were deposited to the European Nu-
cleotide Archive (ENA) under project accession PRJEB8575 (http://www.ebi.ac.uk/ena/data/
view/PRJEB8575).
Carba NP and CarbAcineto NP
A selection of isolates has also been tested for carbapenemase activity with Carba NP and Car-
bAcineto NP using the most recently published protocols [18,19]. In short, a suspension of a
fourth to a third of a 10 μl loop of culture in 100 μl of commercially available lysis buffer
(B-PERII, Thermo Scientific Pierce, Rockford, USA) was mixed with 100 μl of a phenol red so-
lution of pH 7.8 containing 0.6 mg imipenem monohydrate. If a carbapenemase is present in
the solution, the hydrolysis of the imipenem will lower the pH, causing the phenol red to turn
Fig 1. Schematic of the CIM.
doi:10.1371/journal.pone.0123690.g001
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from red to orange or yellow. For Acinetobacter, this protocol has two modifications: the use of
a 5 M NaCl solution instead of the B-PERII lysis buffer and a full 10 μl loop of culture as
an inoculum.
Results
Validation of the CIM
To validate the robustness of the CIM, the influence of a number of variables on the outcome
of the assay was determined. First, the required density of the bacterial suspension used to im-
merse the meropenem disk was assessed. For this purpose, we used three isolates: two isolates
yielding an OXA-48 PCR product: a K. pneumoniae with an MIC of 32 μg/ml and an E. cloacae
with an MIC of 1.5 μg/ml for meropenem and E. coli ATCC 25922 as a negative control. Bacte-
rial suspensions with optical density OD595 2.6, OD595 13 (density obtained with a loop full of
bacteria), and OD595 65 were used (OD595 2.6 correlates with a McFarland value of 11.3). The
suspension with OD595 2.6 yielded negative results for both OXA-48 positive isolates, whereas
both OD595 13 and OD595 65 yielded positive CIM results. The CIM remained negative for all
densities of E. coli ATCC 25922.
A subset of ten isolates from the selection in Table 1 was used to determine the influence of
a number of other variables. First, the incubation time of the meropenem disk in the bacterial
suspension was varied from 30 minutes to overnight. Results indicated that for this subset, 30
minutes were sufficient to obtain correct results. After overnight incubation, the results could
still be assessed, although decreased inhibition zones for the negative control indicated partial
auto-hydrolysis of the meropenem in the disk. However, this was only tested with a small
Table 4. Primers used for PCR detection of carbapenemase encoding genes.
Primer name Primer sequence Product size (bp) Reference
KPC_mp-F CTTGTCTCTCATGGCCGCTGG 449 this study
KPC_mp-R ACGGAACGTGGTATCGCCGAT this study
NDM_mp-F TCCTTGATCAGGCAGCCACC 591 this study
NDM_mp-R CGCATTAGCCGCTGCATTGA this study
VIM_mp-F GCMCTTCTCGCGGAGATTGA 257 this study
VIM_mp-R TGCGCAGCACCRGGATAGA this study
OXA48L-F GCTTGATCGCCCTCGATT 281 [10]
OXA48L-R GATTTGCTCCGTGGCCGAAA [10]
IMP-F GGAATAGAGTGGCTTAAYTCTC 233 [11]
IMP-R2 GGTTTAAYAAAACAACCACC [11]
23S_mp-F GCGATTTCYGAAYGGGGRAACCC 371* [16]
23S_mp-R TTCGCCTTTCCCTCACGGTACT [16]
OXA_23-F GATCGGATTGGAGAACCAGA 501 [12]
OXA_23-R ATTTCTGACCGCATTTCCAT [12]
BIC-F TATGCAGCTCCTTTAAGGGC 537 [11]
BIC-R TCATTGGCGGTGCCGTACAC [11]
OXA48L-R2 CCCTAAACCATCCGATGTGG 516 this study
IMP-mp-F GGAATAGRGTGGCTTAATTC [17]**
IMP-mp-R1 GACTTTGGCCAAGCTTYTA 285 [17]
IMP-mp-R2 GTAAGCTTCAAGAGCGACG 375 [17]
* product size for E. coli, size varies for different species
** Zhao and Hu 2011, F and R1 primers adapted from D-F and A-R primer, respectively; R2 primer identical to C-R primer.
doi:10.1371/journal.pone.0123690.t004
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subset to illustrate the robustness of the method. To improve detection in cases of low-level
carbapenemase activity and to obtain an assay that can still be interpreted within one working
day, a minimum incubation time of 2 hours was chosen. Incubation temperatures of 30°C,
35°C and 37°C all yielded identical results. Suspensions made from isolates grown on Mueller-
Hinton agar and Columbia sheep blood agar plates both resulted in the correct detection of car-
bapenemase activity. However, in cultures grown on Oxoid CRE plates (Oxoid Ltd, Hampshire,
United Kingdom), which contain a chromogenic substrate and a carbapenem, carbapenemase
activity could not be detected in four out of nine carbapenemase positive isolates. Suspensions
made from cultures that had been maintained refrigerated on agar plates for up to two weeks
gave identical results as suspensions made from fresh cultures. Similarly, bacterial suspensions
made from fresh cultures that were subsequently stored for up to two weeks at 4°C, retained
their capability to inactivate the carbapenem in the disk. The CIM was performed using suscep-
tibility-testing disks containing 10 μg meropenem from two different suppliers (Oxoid Ltd,
Hampshire, United Kingdom and Mast Group Ltd, Merseyside, United Kingdom), which
yielded identical results. The addition of zinc sulfate to the suspension, used to stimulate
metallo-betalactamases such as NDM, was tested but no beneficial effect could be demonstrat-
ed. Finally, to assess the influence of human skill on the performance of the CIM, different lab-
oratory staff tested the previously mentioned selection of 30 Gram-negative isolates (Table 1)
and no discrepancies were found.
Application of the CIM on surveillance isolates
Of the 283 Enterobacteriaceae included in the study, 70 (24.7%) were shown to carry a carbape-
nemase encoding gene by PCR and all PCR-positives (100%) were shown to produce carbape-
nemase by the CIM (Table 2). A Proteus mirabilis isolate with an MIC of 0.094 μg/ml for
meropenem yielded a VIM PCR product, but was initially negative for CIM. Like all isolates for
which PCR and CIM yielded discrepant results, the analysis was repeated and CIM was positive
in the second analysis. Two other isolates with MICs 0.25 μg/ml (K. pneumoniae and E. coli)
yielded an OXA-48 PCR product and both isolates were shown to produce carbapenemase.
Three isolates (two K. pneumoniae and one E. coli) produced carbapenemase, but were PCR-
negative using our multiplex PCR. However, they did yield an OXA-48-like PCR product using
a modified reverse primer (OXA-48L-R2, Table 4). Sanger sequencing of the PCR product ob-
tained with this modified primer revealed that all three had allele OXA-181, which cannot be
detected with the original primer set. Nearly half of the K. pneumoniae (47.7%) and E. coli
(48.8%) isolates included in this study yielded a PCR product representing a carbapenemase
encoding gene and all these isolates were CIM-positive. However, we detected a carbapenemase
encoding gene in only a minor fraction of the E. cloacae (5.6%) and the other Enterobacteria-
ceae (3.8%). Again, all PCR-positives were shown to produce carbapenemase by CIM. Of the
26 OXA-48 positive K. pneumoniae isolates, five had a mucoid colony morphology, but this
did not affect the ability of CIM to detect carbapenemase activity. Forty Enterobacteriaceae iso-
lates (14.1%) had MICs for meropenem that were above the EUCAST clinical breakpoint of re-
sistance (>8 μg/ml). In 14 of these (35.0%) no carbapenemase encoding gene or
carbapenemase activity was detected.
The collection contained a large number of non-fermenting Gram-negatives all belonging
to the Pseudomonas and Acinetobacter genera (Table 3). Sixty-seven of the 411 isolates (16.3%)
yielded a PCR product and 65 of these samples (97.0%) yielded a positive CIM. Only in two A.
baumannii isolates carrying blaOXA-23, carbapenemase activity could not be detected with
CIM. All 67 isolates had MICs>0.25 μg/ml. Among the Pseudomonas isolates, VIM was the
most frequently detected carbapenemase encoding gene, present in 49 of the 387 isolates
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(12.7%). In A. baumannii, OXA-23 was the predominant carbapenemase encoding gene, de-
tected in 12 of the 18 isolates (66.7%). None of the other A. spp. were PCR positive. Of the 344
PCR-negative non-fermenter isolates, only seven were CIM-positive (2.0%) and all of these iso-
lates had MICs>0.25 μg/ml. Three of these isolates were found to contain a carbapenemase-
encoding gene using additional PCRs; two Pseudomonas isolates were BIC positive [11] and
one Pseudomonas isolate was found to carry an IMP variant not detected by our multiplex
PCR) [17]. In addition, one CIM-positive A. baumannii isolate was found to contain an OXA-
72 gene by next-generation sequencing. Compared to the Enterobacteriaceae, a larger portion
of the non-fermenter isolates had MICs for meropenem that were above the EUCAST clinical
breakpoint for resistance (222/411, 54.0%). Yet, 164 (73.8%) of these were negative in both
PCR and CIM.
Comparison of CIM with Carba NP
A selection (n = 116) of the isolates subjected to CIM has also been tested with Carba NP or Car-
bAcineto NP using the most recently published protocols [18,19]. These isolates include all iso-
lates used for validation (Table 1), all OXA-48 positive K. pneumoniae isolates as well as all CIM/
PCR discrepant isolates, supplemented with a random selection of other isolates used (Table 5).
Four isolates (3.4%) gave different results for CIM than for Carba NP. Three of these were iso-
lates found to contain a carbapenemase encoding gene (two blaBIC and one blaOXA-48like) where
CIM was positive and Carba NP was (false-) negative. The fourth isolate was a CIM positive
Table 5. Comparison of the CIM and Carba NP test.
Species PCR n CIM+ CarbaNP+
Klebsiella pneumoniae(38) KPC 1 1 1
NDM 5 5 5
OXA-48 28 28 28
IMP 2 2 2
neg 2 0 0
Escherichia coli (8) NDM 1 1 1
OXA-48 3 3 2
neg 4 0 0
Enterobacter cloacae (7) OXA-48 2 2 2
VIM 1 1 1
neg 4 0 0
Other Enterobacteriaceae(16) NDM 1 1 1
VIM 1 1 1
neg 14 0 0
Pseudomonas aeruginosa(5) VIM 3 3 3
IMP 1 1 1
neg 1 0 0
Pseudomonas spp. (8) VIM 1 1 1
IMP 1 1 1
BIC 2 2 1
neg 4 2 1
Acinetobacter baumannii(3) OXA-23 2 0 0
OXA-72 1 1 1
Acinetobacter spp. (1) neg 1 0 0
All isolates 86 54 51
doi:10.1371/journal.pone.0123690.t005
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Pseudomonas spp. for which no carbapenemase encoding gene was identified, but carbapene-
mase activity could not be confirmed with Carba NP.
Discussion
The concept of demonstrating enzymatic hydrolysis of beta-lactam antibiotics by incubating
them with bacterial suspensions is not new and dates back to the late 70s [20]. However, the
CIM is the first to use antibiotic susceptibility-testing disks, which are globally available at low
cost and have long shelf lives, as substrate aliquots for this. This greatly improves practicality
and reduces costs and labor. Furthermore, this method was shown to be unaffected by changes
in variables such as incubation temperature or time, disk manufacturer, laboratory staff and
the age of the culture or bacterial suspension making it a cost-effective and highly robust phe-
notypic screening method that can reliably detect carbapenemase activity. As it requires no
specialized equipment, reagents or skill and low hands-on time to perform, it is a high through-
put method enabling screening of large numbers of isolates in most medical
microbiological laboratories.
The application of the CIM in this study shows that it is capable of detecting carbapenemase
production in Gram-negatives allowing distinction between carbapenem-resistance due to
beta-lactamase activity and reduced permeability. There was a high concordance (100% for
Enterobacteriaceae and 98,8% for non-fermenters) between PCRs that detect carbapenem en-
coding genes and carbapenemase activity detected by CIM. After application of additional
PCRs to the discrepant isolates, all findings with CIM were in accordance with PCRs among
Enterobacteriaceae, giving CIM a positive predictive value and a negative predictive value of
100% for Enterobacteriaceae compared to PCRs. One P.mirabilis isolate showed a remarkable
result: it carried a blaVIM-1 gene, but had a low MIC for meropenem (0.094) and initially
yielded a negative CIM. However, when repeated CIM was positive. Carba NP showed a weak
positive reaction for this isolate. Preliminary results obtained by next-generation sequence
analysis of this isolate strain showed that the blaVIM-1 gene itself was intact and located on a
class I integron-like structure as has been described for other VIM-producing species, such as
P. aeruginosa, K. pneumoniae and another P.mirabilis isolate [21–23]. Expression of resistance
cassettes from integron 1-type structures is mediated by the Pant promoter. Variations in Pant
promoter sequence have been observed in several naturally occurring integrons, and have been
shown to differ at least 20-fold in strength [24], with the promoter sequence found in our P.
mirabilis isolate (TGGACA-N17-TAAGCT) belonging to the weaker promoters. Weak expres-
sion of blaVIM-1 would result in low-level carbapenemase activity around the detection-thresh-
old of CIM, explaining the discrepancy between the two assays performed with this isolate as
well as the low MIC observed.
Initially, there were seven isolates among the non-fermenters that were CIM-positive, but
for which no gene could be identified using the multiplex PCR. After applying additional
PCRs, four isolates remained PCR-negative, one of which could be explained by an OXA-72
gene identified using next-generation sequencing. Of the remaining three false-positive iso-
lates, two were also Carba NP positive, suggesting the presence of a carbapenemase currently
undetectable by our genotypic methods. Conversely, for two OXA-23 positive A. baumannii
isolates no phenotypic carbapenemase activity could be detected using CIM. When CIM was
performed using an extended incubation time of four hours instead of two, CIM was positive
for both Acinetobacter isolates, indicating very weak carbapenemase activity. Carbapenemase
activity could also not be detected for these isolates using CarbAcineto NP (Table 5). The diffi-
culties detecting low-level carbapenemase activity among both these A. baumannii isolates and
the P.mirabilis isolate mentioned earlier can be regarded as a limitation of the CIM. Use of an
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extended incubation time of four hours for all Acinetobacter and Proteus isolates might over-
come this limitation, but further research is required to determine if this will improve detection
without compromising specificity. The five discrepant non-fermenter isolates are considered
false-positive and false-negative. This leads to a positive predictive value of 96.3% and a nega-
tive predictive value of 99.4% for CIM among non-fermenters compared to PCRs.
Additionally, many isolates apparently were resistant for meropenem, but were negative in
both PCR and CIM, suggesting that carbapenem-resistance was mediated by other mecha-
nisms than carbapenemase activity in these isolates, which is currently being investigated by
next-generation sequencing.
In comparison to the Carba NP method [13,14,18,19], CIM has similar high performance
(96.6% concordance, 112/116), but significantly lower cost (€0.60 compared to €13 in our set-
ting). Prices mentioned are based on imipenem and B-PERII buffer as reagents for CarbaNP
and a meropenem disk, Mueller-Hinton agar plate and sterile cotton swab required for CIM.
In addition, we believe that CIM is even easier to perform than Carba NP since there is no need
to prepare a fresh pH adjusted imipenem solution for each test. Moreover, in our experience,
interpretation of results using CIM is also much easier compared to the Carba NP test. Some of
the isolates tested with Carba NP showed a very weak color change that could easily have been
missed in a routine screening setting. However, we should emphasize that this study was not
intended to compare CIM with Carba NP.
Another alternative to detect carbapenemase activity among isolates is an assay based on
matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF
MS). High performance has been reported for this technique, but none of these studies feature
strain collections as large as the one described here [25–28]. Furthermore, this technique re-
quires expensive specialized equipment, which may not be present in all medical microbiolog-
ical laboratories, making it less suited for screening purposes.
The CIM concept has the potential to also be applied to assess enzymatic hydrolysis of other
antibiotics, e.g. allowing detection of ESBL activity. Preliminary experiments in our laboratory
have shown this may be feasible. This will need to be further investigated, but it could represent
an additional advantage over Carba NP, which can only be applied to antibiotics that generate
sufficient acidity upon hydrolysis.
In conclusion, we have shown that the CIM provides a low cost alternative for the Carba NP
test. It allows easy and rapid identification of carbapenemase activity. This provides a tool to
identify carbapenem-resistant Gram-negative bacteria that may easily spread in health
care settings.
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